Ankle Joint Mobilization Decreases Hypersensitivity by Activation of Peripheral Opioid Receptors in a Mouse Model of Postoperative Pain

Pain Medicine (United States)

Volumn 13, Issue 8, 2012, Pages 1049-1058

  Martins, Daniel F ^a,b   Bobinski, Franciane ^a   Mazzardo Martins, Leidiane ^a   Cidral Filho, Francisco J ^a   Nascimento, Francisney P ^a   Gadotti, Vinícius M ^a,c   Santos, Adair R S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

Incisional pain; Manual therapy; Opioid; Passive; Rehabilitation

Indexed keywords

FUCOIDIN; NALOXONE; OPIATE RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANKLE; ARTICLE; CONTROLLED STUDY; HYPERSENSITIVITY; INCISION; JOINT MOBILIZATION; LEUKOCYTE MIGRATION; MALE; MECHANICAL STIMULATION; MOUSE; NOCICEPTION; NONHUMAN; POSTOPERATIVE PAIN;

EID: 84865296095     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2012.01438.x     Document Type: Article

References (42)

1. Cousins MJ, Power I, Smith G. Pain: A persistent problem. Reg Anesth Pain Med 2000;25:6-21.
2. Schug S, Large R. Economic considerations in pain management. Pharmacoeconomics 1993;3:260-7.
3. Moss P, Sluka K, Wright A. The initial effects of knee joint mobilization on osteoarthritic hyperalgesia. Man Ther 2007;12:109-18.
4. Wright A, Sluka KA. Nonpharmacological treatments for musculoskeletal pain. Clin J Pain 2001;17:33-46.
5. Skyba DA, Radhakrishnan R, Rohlwing JJ, Wright A, Sluka KA. Joint manipulation reduces hyperalgesia by activation of monoamine receptors but not opioid or GABA receptors in the spinal cord. Pain 2003;106:159-68.
6. Sluka KA, Wright A. Knee joint mobilization reduces secondary mechanical hyperalgesia induced by capsaicin injection into the ankle joint. Eur J Pain 2001;5:81-7.
7. Fields HL, Basbaum AI. Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R, eds. Textbook of Pain. New York: Churchill Livingstone; 1999:243-57.
8. Ward RC. Headache: An osteopathic perspective. J Am Osteopath Assoc 1982;81:458-66.
9. Zusman M, Edwards B, Donaghy A. Investigation of a proposed mechanism for the relief of spinal pain with passive joint movement. Man Med 1989;4:58-61.
10. Hill RG. The status of naloxone in the identification of pain control mechanisms operated by endogenous opioids. Neurosci Lett 1981;21:217-22.
11. Stein C, Schäfer M, Machelska H. Attacking pain at its source: New perspectives on opioids. Nat Med 2003;9:1003-8.
12. Stein C, Zöllner C. Opioids and sensory nerves. In: Canning BJ, Spina D, eds. Pharmacology of Sensory Nerves. Handbook of Experimental Pharmacology. Heidelberg: Springer; 2009:495-18.
13. Craft RM, Henley SR, Haaseth RC, Hruby VJ, Porreca F. Opioid antinociception in a rat model of visceral pain: Systemic versus local drug administration. J Pharmacol Exp Ther 1995;275:1535-42.
14. Fürst S, Riba P, Friedmann T, etal. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat. J Pharmacol Exp Ther 2005;312:609-18.
15. Labuz D, Mousa SA, Schafer M, Stein C, Machelska H. Relative contribution of peripheral versus central opioid receptors to antinociception. Brain Res 2007;1160:30-8.
16. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983;16:109-10.
17. Pogatzki EM, Raja SN. A mouse model of incisional pain. Anesthesiology 2003;99:1023-7.
18. Maitland GD, ed. Peripheral Manipulation. London: Butterworth-Heinemann; 1991.
19. Bortalanza LB, Ferreira J, Hess SC, etal. Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice. Eur J Pharmacol 2002;25:203-8.
20. Wright A. Hypoalgesia post-manipulative therapy: A review of a potential neurophysiological mechanism. Man Ther 1995;1:11-6.
21. Bement MK, Sluka KA. Low-intensity exercise reverses chronic muscle pain in the rat in a naloxone-dependent manner. Arch Phys Med Rehabil 2005;86:1736-40.
22. Zahn PK, Brennan TJ. Lack of effect of intrathecally administered N methyl-D-aspartate receptor antagonists in a rat model for postoperative pain. Anesthesiology 1998;88:143-56.
23. Zahn PK, Gysbers D, Brennan TJ. Effect of systemic and intrathecal morphine in a rat model of postoperative pain. Anesthesiology 1997;86:1066-77.
24. Brennan TJ, Vandermeulen EP, Gebhart GF. Characterization of a rat model of incisional pain. Pain 1996;64:493-501.
25. Pogatzki-Zahn EM, Shimizu I, Caterina M, Raja SN. Heat hyperalgesia after incision requires TRPV1 and is distinct from pure inflammatory pain. Pain 2005;115:296-307.
26. Martins DF, Mazzardo-Martins L, Gadotti VM, etal. Ankle joint mobilization reduces axonotmesis-induced neuropathic pain and glial activation in the spinal cord and enhances nerve regeneration in rats. Pain 2011;152:2653-61.
27. Melzack R, Wall J, eds. Textbook of Pain. Edinburgh: Churchill Livingstone; 1999.
28. Paungmali A, O'Leary S, Souvlis T, Vicenzino B. Naloxone fails to antagonize initial hypoalgesic effect of a manual therapy treatment for lateral epicondylalgia. J Manipulative Physiol Ther 2004;27:180-5.
29. Funez MI, Ferrari LF, Duarte DB, etal. Teleantagonism. A pharmacodynamic property of the primary nociceptive neuron. Proc Natl Acad Sci U S A 2008;105:19038-43.
30. Buzas B, Cox BM. Quantitative analysis of mu and delta opioid receptor gene expression in rat brain and peripheral ganglia using competitive polymerase chain reaction. Neuroscience 1997;76:479-89.
31. Minami M, Maekawa K, Yabuuchi K, Satoh M. Double in situ hybridization study on coexistence of mu-, delta- and kappa-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia. Brain Res Mol Brain Res 1995;30:203-10.
32. Stein C, Lang LJ. Peripheral mechanisms of opioid analgesia. Curr Opin Pharmacol 2009;9:3-8.
33. Li JL, Kaneko T, Mizuno N. Effects of peripheral nerve ligation on expression of mu-opioid receptor in sensory ganglion neurons: An immunohistochemical study in dorsal root and nodose ganglion neurons of the rat. Neurosci Lett 1996;214:91-4.
34. Mousa SA, Zhang Q, Sitte N, Ji R, Stein C. Beta-endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J Neuroimmunol 2001;115:71-8.
35. Zöllner C, Shaqura MA, Bopaiah CP, etal. Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 2003;64:202-10.
36. Akins PT, McCleskey EW. Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP. Neuroscience 1993;56:759-69.
37. Machelska H. Targeting of opioid-producing leukocytes for pain control. Neuropeptides 2007;41:355-63.
38. Li JL, Ding YQ, Li YQ, etal. Immunocytochemical localization of mu-opioid receptor in primary afferent neurons containing substance P or calcitonin gene-related peptide. A light and electron microscope study in the rat. Brain Res 1998;794:347-52.
39. Stein C. The control of pain in peripheral tissue by opioids. N Engl J Med 1995;332:1685-90.
40. Stein C, Hassan AHS, Lehrberger K, Giefing J, Yassouridis A. Local analgesic effect of endogenous opioid peptides. Lancet 1993;342:321-4.
41. Machelska H, Cabot PJ, Mousa SA, Zhang Q, Stein C. Pain control in inflammation governed by selectins. Nat Med 1998;4:1425-8.
42. Bevilacqua MP, Nelson RM. Selectins. J Clin Invest 1993;91:379-87.